CRON

NASDAQ · Equity

Cronos Group Inc

US Healthcare Drug Manufacturers - Specialty & Generic

Latest week
29 May 2026
Close
2.840000
Fair value
2.229167
Expectation
Negative 42.20%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
2.84
12-Week Change
13.60%
Trend Signal
Active
Expectation
Negative 42.20%
Signal Weeks
1 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
-6.63
Market Dynamics
0.25

Over the latest 12 completed weeks ending 2026-05-29, CRON rose 13.60%, moving from 2.50 to 2.84. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 1 of the last 12 weeks. Relative Strength is -6.63 and has softened across the 12-week window. Market Dynamics is 0.25 on the latest week. Expectation is negative at 42.20%.